SASupriya Atta

Supriya Atta

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Supriya Atta has a total of 70 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Portable amplification-free diagnostics of head and neck squamous cell carcinoma using SERS biosensor with machine learning-assisted classification

    by Khang D. Hoang, Supriya Atta, Elliot A. Grant, Jinjia Zhou, Zimeng Li, Gabriel D. Kantor, Joy Q. Li, Yuanhao Zhao, Tyler Vasse, Gloria L. Dalton, et al.

    Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide, with approximately 890,000 new cases annually, and is associated with disproportionately poor outcomes in low-resource settings due to limited access to early diagnostics and trained personnel. Bridging this gap requires transformative technologies that combine high sensitivity, minimal sample processing, and point-of-care access. Here, we present a portable platform for the direct detection of the mRNA biomarker keratin 14 (KRT14) in HNSCC based on a sandwich hybridization assay coupled with surface-enhanced Raman scattering (SERS) using highly efficient probes: core-gap-shell spiky nanorattles (SpNRs). We systematically investigate the role of adenine spacer length on probe conformation on both magnetic beads (MBs) and SpNRs, as well as its effects on hybridization efficiency and SERS signal enhancement, identifying optimal configurations that enable a picomolar limit of detection without enzymatic amplification. Machine learning models based on the intensity of the characteristic Raman reporter band at 1358 cm⁻1 were used for quantification and classification, discriminating HNSCC from non-cancerous cell-line RNA. In a pilot set of clinical biopsies (two HNSCC patients, three healthy controls), we employed a support vector regression (SVR) classifier, which distinguished cancer from healthy tissue consistent with qRT-PCR, with CatBoost regression used for quantification. Overall, this work presents a nano-plasmonic sensing platform combined with machine learning analysis for nucleic acid detection, with potential applications in point-of-care cancer diagnostics.

  • Smartphone AI-Enabled Lateral Flow Immunoassay Platform Using Advanced Quantum Dots for Intelligent Quantitative Diagnostics

    by Supriya Atta, Taylor L. Thorsen, Tyler Vasse, Vanessa K. Berner, Marcellene A. Gates-Hollingsworth, Haydon J. Hill, David P. AuCoin, Xiaoshan Zhu, Tuan Vo-Dinh

    Lateral flow immunoassays (LFIAs) are widely used in point-of-care diagnostics for their low cost and simplicity, but conventional formats rely on subjective visual readout and lack quantitative accuracy and sensitivity. Here, we present a smartphone-guided, artificial-intelligence-enhanced LFIA platform that unites a rationally engineered dual-modal nanoprobe with on-device machine learning, demonstrated for quantitative detection of Rift Valley fever virus (RVFV). The platform combines three synergistic principles: advanced magnetic quantum dot nanoparticles (AQDs) that integrate a magnetic core and a quantum dot shell in a single label to provide both colorimetric and fluorescence signals while enabling magnetic preconcentration of the target antigen; multi-illumination imaging that turns an ordinary smartphone camera into a quantitative reader; and a machine-learning model that extracts illumination-robust features to convert signal into concentration, removing user subjectivity and lighting sensitivity. This design markedly improves sensitivity over conventional gold-nanosphere LFIA in both modes, enables reliable quantification directly in serum without any pretreatment, and outperforms naked-eye interpretation in blind testing. By coupling dual-modal amplification and magnetic enrichment with AI-driven analysis on widely available hardware, the AQD-LFIA platform offers a scalable route toward next-generation point-of-care and at-home diagnostics.

  • Magneto-Plasmonics-Enhanced Colorimetric Lateral Flow Immunoassay Using Magnetic-Gold Nanostars

    by Supriya Atta, Taylor L. Thorsen, Yuanhao Zhao, Sebastian Sanchez, Haydon J. Hill, Vanessa K. Berner, Marcellene A. Gates-Hollingsworth, Jasmine Pramila Devadhasan, Alexander Jarrett Summers, Jian Gu, et al.

    Colorimetric lateral flow immunoassays (LFIA) have revolutionized point-of-care testing (POCT) methods by providing simple, rapid, accessible, and instrumentation-free detection of infectious diseases. However, conventional LFIAs relying on gold nanospheres (GNPs) can suffer from limited sensitivity due to weak colorimetric signal intensity at the test line, restricting their diagnostic potential. To overcome this limitation, we developed a magneto-plasmonics enhanced colorimetric LFIA (mpLFIA)─a breakthrough platform that integrates a novel hybrid nanoparticle system─magnetic gold nanostars (mpGNS). By leveraging dual enhancement mechanisms─magnetic preconcentration and plasmonic amplification through the gold nanostar shell coating of the magnetic core─the mpLFIA achieves unprecedented signal intensity and detection performance. Among the tested mpGNS variants, mpGNS-3─distinguished by its longest spikes and highest branch density─emerged as the most effective colorimetric signal amplifier when evaluated using Rift Valley fever virus (RVFV) nucleoprotein as a model analyte. Our mpLFIA platform achieves an outstanding limit of detection (LOD) of 2.24 pg/mL for RVFV nucleoprotein in 1X PBS buffer, demonstrating a 1000-fold enhancement over conventional GNP-based assays. Our prototype mpLFIA platform, utilizing highly spiked mpGNS-3, exhibits great potential as a powerful bioanalytical tool, combining high sensitivity with practical portability for point-of-care applications.


  • Top Cited Papers

    Direct, Pretreatment-Free Surface-Enhanced Raman Scattering (SERS) Detection of Uric Acid in Urine Facilitated by Efficient Hydrogen Bonding-Driven Capture

    by Supriya Atta, Tuan Vo-Dinh

    Uric acid, a vital circulating metabolite, is a key biomarker for various health conditions including gout, preeclampsia, and kidney disorders. This underscores the need for noninvasive, rapid, sensitive, and cost-effective methods for monitoring uric acid to enable early preventive interventions. This study introduces a simple and sensitive separation-free "mix-and-detect" method for the direct surface-enhanced Raman scattering (SERS) detection of uric acid in urine, using bimetallic gold-silver nanostars functionalized with sodium dodecyl sulfate (BGNS@SDS). The SDS capping layer facilitates efficient uric acid capture through multiple hydrogen bonds under alkaline conditions, as confirmed by density functional theory (DFT) analysis. Using the optimized nanostar morphology (BGNS-3@SDS), uric acid was detected in water and spiked artificial urine samples with limits of detection of 2.2 and 3 μg/mL, respectively. These detection limits are substantially lower than the clinically relevant concentration range of uric acid in urine and well below the pathological threshold (∼750 μg/mL). The platform also successfully quantified uric acid levels in urine from ten healthy volunteers without sample pretreatment, enabling differentiation between healthy individuals and those at risk. This straightforward and sensitive SERS strategy holds strong promise for rapid, point-of-care diagnostics targeting low-affinity biomarkers.


  • Flexible, and cost-effective 3D nano-cauliflower SERS substrate for antibiotics detection on curved surfaces

    by Supriya Atta, Yuanhao Zhao, Sebastian Sanchez, Tuan Vo-Dinh

    A simple, sensitive, and cost-effective SERS substrate preparation method is introduced, leveraging plasmonics-active gold nanostars (GNS) on commercially available hydrophobic adhesive tape to create a 3D plasmonic nano-cauliflower (PNC) architecture. Using the optimized SERS-active PNC substrate (PNC-5), we achieved ultra-low detection limits of 3.3 nM for ciprofloxacin (CIP) and 1.5 nM for ampicillin (AMP) antibiotics. Our PNC platform exhibits exceptional stability for over six months and outstanding reproducibility with an RSD of less than 5%. Moreover, the PNC platform enables direct detection of CIP and AMP on chicken wing surfaces without any sample pre-treatment. These features underscore its great potential for rapid, on-site food safety and homeland security monitoring. Graphical Abstract


  • A Simple Sensitive Solution-Based “Mix-and-Detect” SERS Platform Utilizing Highly Stable Multibranched Gold Nanostars for Bilirubin Detection in Urine

    by Supriya Atta, Yuanhao Zhao, Sabina Yampolsky, Sebastian Sanchez, Tuan Vo-Dinh

    Bilirubin, a critical circulating metabolite, functions as a key biomarker for a range of health conditions, including jaundice, hepatitis, cirrhosis, and liver disorders. This highlights the need for a straightforward, rapid, sensitive, and cost-effective method for bilirubin monitoring to enable early diagnosis. In this study, we developed a simple and efficient solution-based SERS platform using highly stable gold nanostars (GNS) with tunable spike numbers (7-20) for direct bilirubin detection in urine without any sample pretreatment. Among the variants tested, GNS with the highest spike number (GNS-4) exhibited the strongest SERS enhancement, achieving a detection limit of 7.4 nM with methylene blue (Mb) as a model analyte. GNS-4 also enabled the direct detection of bilirubin spiked in artificial urine at a 20 nM detection limit. Furthermore, our "mix-and-detect" SERS platform effectively monitored bilirubin levels in urine samples from ten healthy volunteers without any pretreatment, highlighting its potential to differentiate healthy individuals from those at risk. Notably, GNS-4 maintained excellent SERS reproducibility and stability after six months of storage at room temperature. These results underscore the potential of solution-based SERS platforms for rapid, reliable, and cost-effective point-of-care diagnostics.


  • Multibranched Magnetic Core–Shell Gold Nanostars for In Situ Solution-Based SERS Detection

    by Supriya Atta, Taylor L. Thorsen, Sebastian Sanchez, Yuanhao Zhao, Tuan Vo-Dinh


  • Plasmonics-Enhanced Dual-Modal Colorimetric and Photothermal Lateral Flow Immunoassay Using Gold Nanocages

    by Supriya Atta, Yuanhao Zhao, Sebastian Sanchez, Sabina V. Yampolsky, Tuan Vo-Dinh

    Lateral flow immunoassays (LFIA) are widely recognized as cost-effective point-of-care diagnostic tools (POCT) for infectious disease diagnosis. Despite their widespread use, traditional colorimetric LFIAs, which rely on gold nanospheres (GNP), are constrained by a limited sensitivity. To overcome this challenge, we have engineered gold nanocages (GNCs) with optimized core-to-shell morphologies, achieving significant amplification of both colorimetric and photothermal LFIA readout signals. The distinctive morphology of GNCs, featuring adjustable core-to-shell gap thicknesses, enables fine-tuning of the localized surface plasmon resonance (LSPR) peak across a broad spectral range from 600 to 1200 nm. Among the GNC morphologies evaluated, the optimized GNC (GNC-4), characterized by its larger size and maximal core-to-shell gap thickness, exhibited superior color brightness and enhanced photothermal efficiency compared to other GNC morphologies and traditional GNP. The enhanced performance of GNC-4 enabled the detection of influenza A (H1N1), used as the model analyte, achieving a limit of detection (LOD) of 1.8 ng/mL via colorimetric analysis and 1.51 pg/mL using photothermal LFIA. Compared to traditional GNP-based colorimetric LFIA detection, the colorimetric sensitivity of the GNC-4-based LFIA was enhanced by 7-fold, while the photothermal detection sensitivity showed an improvement of over 8000-fold. By incorporating a portable smartphone-based photothermal LFIA platform, our dual-modal LFIA exhibits high sensitivity, practicality in detecting H1N1 in spiked saliva samples, and long-term stability over five months, making it a promising tool for infectious disease detection and a potential model for diagnosing other pathogens.


  • Open Access

    Magneto-Plasmonics-Enhanced Colorimetric Lateral Flow Immunoassay Using Magnetic-Gold Nanostars

    by Supriya Atta, Taylor Thorsen, Yuanhao Zhao, Sebastian Sanchez, Haydon J. Hill, Vanessa K. Berner, Marcellene A. Gates-Hollingsworth, Jasmine Pramila Devadhasan, Alexander Jarrett Summers, Jian Gu, et al.

    Colorimetric lateral flow immunoassays (LFIA) have revolutionized point-of-care testing (POCT) methods by providing simple, rapid, accessible, and instrumentation-free detection of infectious diseases. However, conventional LFIAs relying on gold nanospheres (GNPs) can suffer from limited sensitivity due to weak colorimetric signal intensity at the test line, restricting their diagnostic potential. To overcome this limitation, we developed a magneto-plasmonics enhanced colorimetric LFIA (mpLFIA)- a breakthrough platform that integrates a novel hybrid nanoparticle system-magnetic gold nanostars (mpGNS). By leveraging dual enhancement mechanisms - magnetic preconcentration and plasmonic amplification through the gold nanostar shell coating of the magnetic core- the mpLFIA achieves unprecedented signal intensity and detection performance. Among the tested mpGNS variants, mpGNS-3- distinguished by its longest spikes and highest branch density- emerged as the most effective colorimetric signal amplifier when evaluated using Rift Valley fever virus (RVFV) nucleoprotein as a model analyte. Our mpLFIA platform achieves an outstanding limit of detection (LOD) of 2.24 pg/mL for RVFV nucleoprotein in 1X PBS buffer, demonstrating a 1000-fold enhancement over conventional GNP-based assays. Our prototype mpLFIA platform, utilizing highly spiked mpGNS-3, exhibits great potential as a powerful bioanalytical tool, combining high sensitivity with practical portability for point-of-care applications.


  • Plasmonic-Enhanced Colorimetric Lateral Flow Immunoassays Using Bimetallic Silver-Coated Gold Nanostars

    by Supriya Atta, Yuanhao Zhao, Sebastian Sanchez, Deven Seedial, Jasmine Pramila Devadhasan, Alexander Jarrett Summers, Marcellene A. Gates-Hollingsworth, Kathryn J Pflughoeft, Jian Gu, Douglas C. Montgomery, et al.

    The colorimetric lateral flow immunoassay (cLFIA) has gained widespread attention as a point-of-care testing (POCT) technique due to its low cost, short analysis time, portability, and capability of being performed by unskilled operators with minimal requirement of reagents. However, the low analytical sensitivity of conventional LFIA based on colloidal gold nanospheres limits their applications for sensitive detection of trace amounts of target analytes. In this study, we introduced a novel plasmonic-enhanced colorimetric LFIA (PE-cLFIA) platform featuring bimetallic silver-coated gold nanostars (BGNS) with exceptional optical properties, leading to ultrahigh visual color brightness. The BGNS-based PE-cLFIA was successfully applied to detect a model analyte, low-calcium response V (LcrV), a virulence protein factor found in Yersinia pestis, the causative agent of bubonic plague. The PE-cLFIA sensing using BGNS-3 composed of 45 nm silver thickness showed a high visual colorimetric sensitivity with a detection limit as low as 13.7 pg/mL, which was around 50 times more sensitive than that of a traditional gold nanoparticle-based LFIA. In addition, the antibody-conjugated BGNS-3 showed excellent stability over 6 months. To illustrate the potential for clinical applications, we demonstrated that our LFIA platform for detecting LcrV spiked in human serum without any sample preprocessing exhibited a detection limit of 22.8 pg/mL. These results open up new opportunities for developing hybrid nanoparticle systems for sensitive POCT PE-cLFIA screening for infectious disease detection.